Showing 7,467 results

Filters Content type: News, Editors' picks Country: North America
New & experimental hepatitis C treatment

New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

News
1 February 2016
Treatment guidelines

US: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Editor's pick
AIDS.info
1 February 2016
Government, leadership & policy

Only 3 Presidential Candidates Share How They Will Address HIV

Editor's pick
HIVPlus
1 February 2016
New & experimental hepatitis C treatment

Zepatier for hepatitis C approved in Canada

Editor's pick
CATIE
1 February 2016
Dating, relationships & feelings

How to Talk to Your Partner About Going on PrEP

Editor's pick
HIV Plus
1 February 2016
HIV & criminal law

Criminal laws on HIV transmission make little difference to sexual behaviour – or may make condomless sex more likely

News
1 February 2016
PrEP

We Aren’t the Sex Police: What PrEP Providers Say About Condoms & STIs

Editor's pick
BETA blog
30 January 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Hepatitis C transmission & prevention

HCV on the Rise in Dialysis Patients, CDC Warns

Editor's pick
MedPage Today HIV/AIDS
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Pharmaceutical industry

Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

Editor's pick
New York Times
28 January 2016
Cancer

US study shows importance of access to chemotherapy for HIV-positive patients with Hodgkin lymphoma

News
28 January 2016
The search for a cure

HIV protein manipulates hundreds of human genes to advance progression into AIDS, study shows

Editor's pick
UT Southwestern Medical Center
28 January 2016
Pharmaceutical industry

Massachusetts official challenges Gilead's hepatitis C drug prices

Editor's pick
Reuters
28 January 2016
The search for an HIV prevention vaccine

About that latest big Gates Foundation bet for HIV prevention

Editor's pick
Inside Philanthropy
27 January 2016
New & experimental HIV treatments

CytoDyn Announces HIV-Patients Approaching 17 Months of Complete Viral Suppression With PRO 140 Monotherapy

Editor's pick
Cytodyn Inc.
27 January 2016
Pharmaceutical industry

AHF Files Federal Lawsuit Against Gilead to Invalidate Patents on Key AIDS Drug

Editor's pick
AIDS Healthcare Foundation
27 January 2016
New & experimental HIV treatments

Experimental Combination Surprises with Anti-HIV Effectiveness

Editor's pick
National Institute of Mental Health
27 January 2016
Drug interactions & pharmacokinetics

People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

News
27 January 2016
Harm reduction

UNGASS Without Harm Reduction? No Way!

Editor's pick
Drug Reporter
26 January 2016
Harm reduction

HRI has serious concerns with draft UNGASS outcome document

Editor's pick
Harm Reduction International
26 January 2016
Access to healthcare

Big Pharma’s worst nightmare

Editor's pick
The Guardian
26 January 2016
PrEP

Here's Free Info on PrEP Specifically for Trans Women and Men

Editor's pick
Poz magazine news
26 January 2016